U.S. Software Stock News

Key Insights Using the 2 Stage Free Cash Flow to Equity, Amdocs fair value estimate is US$130 Amdocs is estimated to be...

Arcturus Therapeutics Holdings Inc. recently presented at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026, at the Westin St. Francis Hotel in San Francisco, with Founder, President, CEO and Director Joseph E. Payne speaking. This high-profile conference appearance offered Arcturus a platform to showcase its pipeline and corporate story to a concentrated audience of healthcare-focused investors and industry peers. With this conference spotlight and recent share price...

Masimo Corporation has already presented at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco and released preliminary fourth-quarter and full-year 2025 results indicating approximately 12% quarterly and 9% annual revenue growth. Management also highlighted a record level of incremental contract value from new and expanded hospital agreements, underscoring the importance of long-term customer relationships to the business. We’ll now examine how the record incremental...

Honat Bancorp (HONT) has put another solid quarter on the board, with Q2 2025 revenue of US$11.4 million and basic EPS of US$2.57 feeding into trailing twelve month EPS of US$10.46 on revenue of US$44.6 million and net income of US$15.0 million. Over the past year, the company has seen revenue move from US$38.8 million to US$44.6 million on a trailing basis, while EPS climbed from US$8.33 to US$10.46, and earnings growth of 19% has supported a net profit margin of 33.5% compared with 31.2% a...

If you are wondering whether CareDx at around US$20.19 is starting to look interesting again, you are not alone. This article is here to help you think through the value question. The share price has seen a 7.3% gain over the last week, while the 30 day return sits at a 1.8% decline and the 1 year return is a 8.4% decline. This is against a 42.3% gain over 3 years and a 78.4% decline over 5 years. Recent news coverage of CareDx has focused on how investors are reassessing the company in...

3D Systems recently presented at the 28th Annual Needham Growth Conference while highlighting expanded Aerospace & Defense operations, new FDA clearance for its VSP Orthopedics platform, and balance-sheet strengthening through equity-funded debt reduction. Together, the push into defense-focused manufacturing, broader orthopedic indications, and efforts to reinforce the capital structure underscore how the company is repositioning around mission-critical, higher-value applications. We’ll now...

Autolus Therapeutics recently reported preliminary unaudited 2025 net product revenue of about US$75 million and issued 2026 guidance of US$120 million to US$135 million, alongside progressing obe-cel into Phase 2 trials for lupus nephritis and other indications. The company also secured UK and EU approvals for AUCATZYL®, pairing early commercial traction with expanding clinical data in both pediatric oncology and autoimmune disease. Next, we’ll examine how this combination of higher revenue...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

As the U.S. market navigates a landscape marked by fluctuating indices and inflation data that aligns with expectations, investors are keenly assessing the implications for high-growth sectors like technology. In this environment, identifying promising tech stocks involves evaluating companies that demonstrate resilience amidst economic shifts and possess innovative capabilities to capitalize on emerging opportunities.

As the U.S. stock market navigates through a landscape of record highs and inflationary pressures, investors are keenly assessing the implications of recent consumer price index data and corporate earnings reports. In this environment, identifying undervalued stocks requires a careful analysis of fundamentals and market sentiment, offering potential opportunities for those looking to capitalize on discrepancies between current valuations and intrinsic worth.

As the U.S. stock market navigates a period of cautious optimism following recent inflation data and mixed corporate earnings, investors are increasingly focused on identifying resilient growth opportunities. In this context, companies with high insider ownership often stand out as promising candidates, suggesting that those who know the business best have confidence in its future prospects.

As the U.S. stock market experiences a pullback with investors assessing CPI inflation data and major bank earnings, attention turns to alternative investment opportunities like penny stocks. Often considered an outdated term, penny stocks still hold relevance as they represent smaller or newer companies that can offer growth potential at lower price points. When these companies are backed by strong financial fundamentals, they present intriguing options for investors seeking hidden value in...

As the U.S. market navigates a landscape marked by recent inflation data and fluctuating key indices, investors are closely monitoring the performance of small-cap stocks within the S&P 600. With economic indicators showing resilience amid cautious optimism, identifying promising opportunities in lesser-known stocks can be crucial for those seeking to capitalize on potential growth. In this environment, a good stock often exhibits strong fundamentals and adaptability to changing economic...

Despite an already strong run, Planet Labs PBC ( NYSE:PL ) shares have been powering on, with a gain of 39% in the last...

Penske Automotive Group, Inc.'s ( NYSE:PAG ) price-to-earnings (or "P/E") ratio of 11.5x might make it look like a buy...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

With a price-to-sales (or "P/S") ratio of 9.7x Cellebrite DI Ltd. ( NASDAQ:CLBT ) may be sending very bearish signals...

Babcock & Wilcox Enterprises, Inc. ( NYSE:BW ) shares have continued their recent momentum with a 38% gain in the last...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

You may think that with a price-to-sales (or "P/S") ratio of 9.9x Senseonics Holdings, Inc. ( NASDAQ:SENS ) is a stock...

In the United States, major indices like the S&P 500 and Dow Jones Industrial Average have recently reached new highs, reflecting a market that seems resilient despite ongoing concerns such as the DOJ probe into Fed Chair Powell. This environment of record-setting performance in large-cap stocks often prompts investors to explore opportunities in small-cap companies, which can offer unique growth potential. Identifying promising small-cap stocks requires careful consideration of factors such...

As the U.S. market continues to reach new highs, with the S&P 500 and Dow Jones Industrial Average setting records despite concerns over a DOJ probe into Fed Chair Powell, investors are keeping a keen eye on high-growth tech stocks that could benefit from the current economic climate. In this environment, a good stock to watch is one that demonstrates resilience and adaptability in leveraging technological advancements to navigate market fluctuations effectively.

To the annoyance of some shareholders, Flora Growth Corp. ( NASDAQ:FLGC ) shares are down a considerable 26% in the...